H.C. Wainwright lowered the firm’s price target on Brainsway (BWAY) to $15 from $30 and keeps a Buy rating on the shares to reflect the recent change effected in the ratio of American Depositary Shares to ordinary shares. Previously, this ratio was one ADS for every two ordinary shares, but earlier this month it was revised to a one-to-one ratio, the analyst noted. In the wake of a “solid performance in 2025, the firm sees a positive medium- to long-term outlook, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- Midday Fly By: IEA to release 400M oil barrels, Oracle reports Q3 beat
- BrainsWay Posts Record 2025 Results and Issues Bullish 2026 Outlook on Deep TMS Momentum
- Brainsway reports Q4 EPS 7c, consensus 3c
- Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M
- Brainsway’s New Deep TMS Depression Study Completion: What Investors Should Watch Next
